ELV Elevance Health
Updated
Financial · Hospital & Medical Service Plans
Elevance Health (ELV) is a financial company in the Hospital & Medical Service Plans industry, with a market capitalization of $89.9 billion. Shares last traded at $414.74, 6.2% below their 52-week high. Over the past year the stock is up 28.9%. ELV trades at a price-to-earnings ratio of 18.12, below the Hospital & Medical Service Plans median of 25.49. Net profit margin is 2.5%, above the peer median of 1.1%. Revenue grew 12.5% year over year. The shares yield 1.7% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
ELV Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $1.53B | $6.81 | 27% |
| 2024-12-31 | $1.51B | $6.47 | 25% |
| 2023-12-31 | $1.40B | $5.88 | 23% |
| 2022-12-31 | $1.23B | $5.06 | 21% |
| 2021-12-31 | $1.10B | $4.47 | 18% |
| 2020-12-31 | $954M | $3.75 | 21% |
| 2019-12-31 | $818M | $3.14 | 17% |
| 2018-12-31 | $776M | $2.94 | 21% |
| 2017-12-31 | $705M | $2.63 | 18% |
| 2016-12-31 | $684M | $2.55 | 28% |
| 2015-12-31 | $657M | $2.41 | 26% |
| 2014-12-31 | $481M | $1.68 | 19% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $14.73 | 2026-07-15 |
| Q1 2026 | $8.00 | 2026-04-22 |
| FY 2025 | $25.21 | 2026-02-06 |
| Q3 2025 | $22.67 | 2025-10-21 |
| Q2 2026 | $17.33 | 2026-07-15 |
| Q1 2026 | $9.61 | 2026-04-22 |
Hospital & Medical Service Plans peers
ELV vs 10 industry peers (Hospital & Medical Service Plans), by market cap. Updated
| UNH | UnitedHealth Group | $359.9B | 25.49 | 0.80 | 3.1% | +0.33% |
| ELV | Elevance Health | $89.9B | 18.12 | 0.45 | 2.5% | +2.21% |
| CI | Cigna | $75.6B | 12.70 | 0.27 | 2.1% | +1.23% |
| HUM | Humana | $48.8B | 43.19 | 0.36 | 0.8% | +1.12% |
| CNC | Centene Corporation | $33.6B | -6.59 | 0.19 | -2.9% | +0.98% |
| MOH | Molina Healthcare, Inc. | $10.6B | -1513.80 | 0.24 | -0.0% | +0.21% |
| OSCR | Oscar Health, Inc. | $9.7B | 17.57 | 0.83 | 4.7% | +6.21% |
| ALHC | Alignment Healthcare, Inc. | $2.8B | 69.01 | 0.61 | 0.9% | -0.37% |
| CLOV | Clover Health Investments, Corp. /De | $2.2B | -26.06 | 0.90 | -3.5% | -1.28% |
| TRUP | Trupanion, Inc. | $1.3B | 64.96 | 0.83 | 1.3% | +1.77% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.